Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Adults with high-risk Relapsed/Refractory ALL.
Ibrahim AldossSamer K KhaledXiuli WangJoycelynne PalmerYan WangJamie R WagnerMary C ClarkJennifer SimpsonJinny PaulVibhuti VyasSheng-Hsuan ChienAnthony S SteinVinod A PullarkatAmandeep SalhotraMonzr M Al MalkiSandra H ThomasL Elizabeth Elizabeth BuddeGuido MarcucciChristine E BrownStephen J FormanPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Tn/mem-derived CD19-CAR T cells were safe and active, including in Philadelphia-like ALL and EMD.